| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2005;45:612.)
© 2005 American Heart Association, Inc.
Original Articles |
From the Autonomic Dysfunction Center, Division of Clinical Pharmacology, Departments of Medicine, Pharmacology, Neurology, and Biostatistics, Vanderbilt University, Nashville, Tenn.
Reprint requests to David Robertson, MD, AA3228, MCN Vanderbilt University, 1161 21st Ave S, Nashville, TN 37232-2195. E-mail david.robertson{at}vanderbilt.edu
The autonomic effects of modafinil (Provigil), a psychostimulant widely used to attenuate fatigue and promote wakefulness, are currently unexplored. We assessed the effect of modafinil on autonomic nervous system. We compared oral modafinil (400 mgx1) versus placebo in 12 healthy hospitalized normal subjects in a randomized double-blind, placebo-controlled cross-over study for 3 days each with subjects in 150 mEq sodium, 70 mEq potassium balance at the Vanderbilt General Clinical Research Center. Modafinil increased resting heart rate (9.2±2.0 bpm; mean [±SE]; 95% confidence interval [CI], 4.7 to 13.6; P=0.001), resting systolic blood pressure (7.3±3.2 mm Hg; 95% CI, 0.2 to 14.4; P=0.044), and resting diastolic blood pressure (5.3±1.7 mm Hg; 95% CI, 1.4 to 9.1 mm Hg; P<0.012). Modafinil elicited a 42% higher orthostatic increase in plasma norepinephrine (0.8±0.3 nmol/L; 95% CI, 0.2 to 1.3; P=0.01), and caused a 33% increase in urine norepinephrine (5.1±1.1 nmol/L creatinine per day; 95% CI, 2.7 to 7.4, P=0.001), and an 81% increase in urine epinephrine (1.3±0.2 nmol/L creatinine per day; 95% CI, 1 to 2; P<0.001). The peroneal microneurographic sympathetic activity was attenuated by modafinil during orthostatic tilt (P<0.001).
1-Adrenoreceptor function was maintained. Modafinil substantially perturbs autonomic cardiovascular regulation by increase in heart rate and blood pressure. Autonomic changes of this magnitude encourage caution in use of modafinil in patients with cardiovascular disease.
Key Words: blood pressure catecholamines heart rate norepinephrine baroreflex
This article has been cited by other articles:
![]() |
D. A. Calhoun, D. Jones, S. Textor, D. C. Goff, T. P. Murphy, R. D. Toto, A. White, W. C. Cushman, W. White, D. Sica, et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Circulation, June 24, 2008; 117(25): e510 - e526. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Calhoun, D. Jones, S. Textor, D. C. Goff, T. P. Murphy, R. D. Toto, A. White, W. C. Cushman, W. White, D. Sica, et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Hypertension, June 1, 2008; 51(6): 1403 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.H. Hou, R.W. Langley, E. Szabadi, and C.M. Bradshaw Comparison of diphenhydramine and modafinil on arousal and autonomic functions in healthy volunteers J Psychopharmacol, August 1, 2007; 21(6): 567 - 578. [Abstract] [PDF] |
||||
![]() |
M. V. Dzurik, A. Diedrich, B. Black, S. Y. Paranjape, S. R. Raj, D. W. Byrne, and D. Robertson Endogenous substance P modulates human cardiovascular regulation at rest and during orthostatic load J Appl Physiol, June 1, 2007; 102(6): 2092 - 2097. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Samuels, R. H. Hou, R. W. Langley, E. Szabadi, and C. M. Bradshaw Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers J Psychopharmacol, November 1, 2006; 20(6): 756 - 770. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |